Lv3
276 积分 2023-02-22 加入
Sacituzumab tirumotecan in previously treated metastatic triple-negative breast cancer: a randomized phase 3 trial
14天前
已完结
Overall Survival with Pembrolizumab in Early-Stage Triple-Negative Breast Cancer
1个月前
已完结
Tankyrase-targeted therapeutics: expanding opportunities in the PARP family
1个月前
已完结
Cantharidin Causes Hepatotoxicity by Disrupting GSH‐Mediated Redox Homeostasis
1个月前
已完结
CDK4/6 Inhibitor Can Improve Niraparib Sensitivity and Reverse Acquired Drug Resistance Through Endonuclease G Nuclear Translocation in BRCA Wild‐Type Ovarian Cancer: A Vitro Study
2个月前
已完结
Beyond BRCA: Diagnosis and management of homologous recombination repair deficient pancreatic cancer
2个月前
已完结
ABT-888, an Orally Active Poly(ADP-Ribose) Polymerase Inhibitor that Potentiates DNA-Damaging Agents in Preclinical Tumor Models
2个月前
已完结
PARP1-DNA co-condensation: the driver of broken DNA repair
2个月前
已完结
Rucaparib maintenance for newly diagnosed advanced ovarian cancer: interim overall survival, progression-free survival, and safety at 5 years of follow-up from the phase III ATHENA-MONO/GOG-3020/ENGOT-ov45 study
2个月前
已完结
On the dehydrogenation of N,N′-substituted p-phenylenediamine antioxidants. I. N-Phenyl-N′-isopropyl-p-phenylenediamine (IPPD)
3个月前
已完结
皖公网安备34019202002308
